Home

Prognosis

Read time: 3 min

Satellite symposium

Maintaining functioning in bipolar disorder: Treat early and prevent relapses

Bipolar disorder (BD) should be considered a neuroprogressive disorder with poor outcomes1 said...

Read time: 2 min

Congress highlights

Beyond the guidelines: Precision Medicine

Despite the attractiveness of precision medicine (PM) for providing personalized patient management...

Depression, Schizophrenia

Read time: 4 min

Congress highlights

Lifestyle, the gut, and mental health

Interventions to lower the risk for cardiovascular disease and metabolic syndrome, correction of...

Alzheimer's Disease

Read time: 4 min

Congress highlights

What have we learned from Alzheimer’s trials?

Recent phase 3 trials in Alzheimer’s Disease teach us how to improve selection of patients so...

Parkinson's Disease

Read time: 5 min

Biomarkers – ever closer in PD

For some time now, researchers have been seeking effective biomarkers for the diagnosis and...

Read time: 4 min

Refining and redefining diagnosis and prognosis in psychosis: can biomarkers and imaging help?

Consortia the world over are seeking biomarkers, including abnormalities on brain imaging, that...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Why does the cellular response to amyloid determine whether an individual develops Alzheimer’s disease?

What happens in the three decades between amyloid-beta (Aβ) deposition in the brain and the...

Read time: 4 min

Train, test, predict: Using big data and machine learning in psychiatry

Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine...

Bipolar, Schizophrenia

Read time: 3 min

Brain connectivity in early psychosis and during effective antipsychotic therapy

Resting state functional MRI of the brain is providing fascinating insights into the connectivity...

Alzheimer's Disease

Read time: 3 min

Congress highlights

It’s in the blood – identification of plasma biomarkers brings hope for screening and early detection of Alzheimer’s disease

The recent discovery and validation of blood biomarkers offers huge potential for the early...

Read time: 3 min

Marking time: does lack of change raise more questions than answers?

We urgently need markers that reveal people’s risk of developing PD and, if they already have...

Bipolar, Schizophrenia

Read time: 4 min

Controversial issues in the management of schizophrenia

Controversial issues in the management of schizophrenia — brain shrinkage, dopamine...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country